Novel anti-TNF-alpha therapy to improve Equine perforamce and quality of life
Grant
Overview
Affiliation
View All
Overview
abstract
The reason for the proposed research is to develop an effective equine specific anti-cytokine therapy that will not induce immunogenicity and can be used to treat major health concerns like colic, stress-induced injuries, and osteoarthritis. This research is necessary and innovative because there is not yet an effective equine therapy targetingproinflammatory cytokines. In addition, this research will evaluate a therapy that is completely novelby overexpressing modified cytokine receptorson MSCs, producing a dual approach, which incorporates the benefits of MSC and anti-cytokine therapies. This research will have a significant impact to the improvement of equine performance and longevity of work life, enhance benefits from MSCs by decreasing cytokine-induced apoptosis, and may open the door to new anti-cytokinetherapies for other species, including humans.
